Goldman Sachs’s Cogentix Medical, Inc. CGNT Stock Holding History

Goldman Sachs’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-92,663	Closed	-$357K	–	6299
2018 Q1	$357K	Buy	+92,663	New	+$290K	﹤0.01%	4690
2017 Q3	–	Sell	-18,842	Closed	-$33K	–	7038
2017 Q2	$33K	Buy	18,842 +1,792	+11%	+$3.07K	﹤0.01%	6461
2017 Q1	$31K	Buy	+17,050	New	+$33.7K	﹤0.01%	6417

Goldman Sachs's CGNT Position: Q2 2018 in Review

Goldman Sachs sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 92,663 shares — an estimated $357K sold.

Goldman Sachs first reported a position in CGNT in Q1 2017 and held it in 3 quarters. The position peaked at $357K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Goldman Sachs reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Goldman Sachs sold 92,663 Cogentix Medical, Inc. shares in Q2 2018, an estimated $357K.
Goldman Sachs first reported a position in Cogentix Medical, Inc. in Q1 2017 and held it in 3 quarters.
Goldman Sachs's Cogentix Medical, Inc. position peaked at $357K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Goldman Sachs's 13F filing for Q2 2018, filed 14 Aug 2018.